Investor Overview

$1,000,000,000
Total Funds Raised
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. We have a team of investment professionals, located in the US and UK. As a Team, our experience spans basic science, industry and the market. We take an active role in our portfolio companies and work with management teams and our fellow venture investors to create significant value. Our current portfolio includes approximately 35 private and public companies and since our founding in 1985, we have invested over $830MM in the biotech space. Our expanded remit also focuses on maximizing the value of GSK technological innovation to establish new businesses and revenue opportunities across a range of industries.

Investment Preference

Business Model
B2B
Series
Series C
Offering Type
Software
AI Techologies

Investment Portfolio

1

Portfolio Companies

Startup

Operating Status

Business Model

Total Funding

AI Employees

Active
B2B
$80,000,000

Investment Rounds History

1

Funding Rounds

Startup

Date Announced

Funding Round

Amount Raised

Investors

September 2020
View All Investors (11 Total)

In The News

© 2021 StartupHub.ai. All rights reserved.

You cannot copy content of this page

Sign up for free

  • Save profiles to your list
  • Basic search functionality

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database